Neuberger Berman Group LLC decreased its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) by 4.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,040,925 shares of the company’s stock after selling 49,273 shares during the period. Neuberger Berman Group LLC’s holdings in Acadia Healthcare were worth $68,217,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Point72 Hong Kong Ltd purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $38,000. Quent Capital LLC purchased a new position in shares of Acadia Healthcare during the 4th quarter valued at approximately $115,000. Tranquility Partners LLC purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $209,000. Walleye Capital LLC purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $216,000. Finally, Inspire Investing LLC purchased a new position in shares of Acadia Healthcare during the 1st quarter valued at approximately $235,000. Hedge funds and other institutional investors own 99.79% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft raised their price objective on Acadia Healthcare from $70.00 to $82.00 in a report on Monday, August 1st. SVB Leerink raised their target price on Acadia Healthcare from $95.00 to $103.00 and gave the stock an “outperform” rating in a research note on Friday, August 26th. UBS Group raised their target price on Acadia Healthcare from $82.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, July 28th. Jefferies Financial Group raised their target price on Acadia Healthcare from $85.00 to $95.00 in a research note on Thursday, July 28th. Finally, Loop Capital assumed coverage on Acadia Healthcare in a research report on Thursday, June 16th. They set a “hold” rating and a $72.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.88.
Insider Buying and Selling at Acadia Healthcare
Acadia Healthcare Stock Performance
NASDAQ ACHC opened at $84.17 on Friday. The company has a market cap of $7.65 billion, a P/E ratio of 27.60, a P/E/G ratio of 2.01 and a beta of 1.28. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.17 and a quick ratio of 1.17. The stock has a 50-day moving average of $80.73 and a two-hundred day moving average of $72.97. Acadia Healthcare Company, Inc. has a 1-year low of $50.07 and a 1-year high of $86.75.
Acadia Healthcare (NASDAQ:ACHC – Get Rating) last released its earnings results on Wednesday, July 27th. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.07. The company had revenue of $651.72 million during the quarter, compared to the consensus estimate of $650.80 million. Acadia Healthcare had a return on equity of 10.34% and a net margin of 11.32%. Acadia Healthcare’s revenue was up 11.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.71 EPS. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.08 EPS for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.
- Get a free copy of the StockNews.com research report on Acadia Healthcare (ACHC)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It’s a Down Week
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.